CNE100004Q23
CNE100004Q23
SINO BIOLOGICAL
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 699.564.604 | 613.671.517 | 14.0% |
| Cost of Revenue | 186.853.762 | 163.916.261 | 14.0% |
| Gross Profit | 512.710.843 | 449.755.256 | 14.0% |
| 408.292.362 | 395.035.095 | 3.4% | |
| Operating Income | 104.418.481 | 54.720.162 | 90.8% |
| Pretax Income | 179.538.494 | 141.332.748 | 27.0% |
| Net Income Common Stockholders | 147.735.828 | 121.927.677 | 21.2% |
| -- | -- | -- | |
| -- | -- | -- |